Antimicrobial susceptibility of Branhamella catarrhalis isolates from bronchopulmonary infections.

AUTOR(ES)

Ahmad, F

RESUMO

Fifty-four clinical isolates of Branhamella catarrhalis from patients with bronchopulmonary infections were studied. The MICs for 50 and 90% of the isolates and the geometric mean MICs were determined for 11 antimicrobial agents. All the strains were resistant to trimethoprim but were susceptible to clavulanate-potentiated amoxicillin (Augmentin; Beecham Research Laboratories, London), chloramphenicol, co-trimoxazole, erythromycin, cefotaxime, and cefuroxime. Beta-lactamase-negative strains were uniformly susceptible to penicillin and ampicillin.

Documentos Relacionados

• Antimicrobial susceptibility testing of Haemophilus influenzae, Branhamella catarrhalis, and Neisseria gonorrhoeae.
• Disk diffusion susceptibility testing of Branhamella catarrhalis with ampicillin and seven other antimicrobial agents.
• Antimicrobial Susceptibility of Bordetella bronchiseptica Isolates from Porcine Respiratory Tract Infections
• Tetracycline and erythromycin resistance among clinical isolates of Branhamella catarrhalis.
• Antibiotic Susceptibility of Beta-Lactamase-Producing Strains of Branhamella (Neisseria) catarrhalis